Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial.
OBJECTIVE
To evaluate the effective dose of Lactobacillus rhamnosus GG (LGG) as probiotic in acute watery diarrhea (AWD) in Indian children.


METHODS
Hospital-based study.


METHODS
Randomized, controlled, blinded trial.


METHODS
All patients of AWD admitted over 1 year were included in the study. They were randomized into 3 groups to receive either only oral rehydration solution (ORS) (group A/control), ORS+LGG powder containing 10(10) colony forming units (CFU) (group B), or ORS+LGG powder containing 10(12) CFU (group C) twice daily for a minimum period of 7 days or until diarrhea stopped along with correction of dehydration. None of them received any other drug such as antibiotic or antidiarrheal medication. The duration and frequency of diarrhea and vomiting were studied. Data were analyzed by SPSS-10 software.


RESULTS
The study comprised of 559 patients, group A/controls (n=185), group B (n=188), and group C (n=186). All the groups were similar with respect to age, number of breastfed infants, presentation with dehydration, degree of protein energy malnutrition, and rotavirus infection. The frequency and duration of diarrhea, requirement for intravenous therapy, and hospital stay were significantly lower in both the intervention groups compared with the controls. There was no significant difference between the 2 intervention groups. No complication was observed from the doses of LGG used.


CONCLUSIONS
Both the doses of LGG (10(10) and 10(12) CFU) were equally effective to decrease the frequency and duration of diarrhea and reduction in hospital stay in patients of AWD.
Basu
Sriparna
S
Department of Pediatrics, North Bengal Medical College and Hospital, Sushrutnagar, Darjeeling, India. drsriparnabasu@rediffmail.com
Paul
Dilip Kumar
DK
Ganguly
Sutapa
S
Chatterjee
Mridula
M
Chandra
Pranab Kumar
PK
D000208:Acute Disease; D000284:Administration, Oral; D001639:Bicarbonates; D015169:Colony Count, Microbial; D003131:Combined Modality Therapy; D003968:Diarrhea, Infantile / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005440:Fluid Therapy; D005947:Glucose; D006801:Humans; D007194:India; D007223:Infant; D052201:Lacticaseibacillus rhamnosus; D007902:Length of Stay; D008297:Male; D011189:Potassium Chloride; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use*; D011502:Protein-Energy Malnutrition / Q000453:epidemiology; D012965:Sodium Chloride; D016896:Treatment Outcome; D014839:Vomiting / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*
D001639:Bicarbonates; C044142:World Health Organization oral rehydration solution; D012965:Sodium Chloride; D011189:Potassium Chloride; D005947:Glucose